MSOS vs. CNBS

The year-to-date returns for both investments are quite close, with MSOS having a -26.25% return and CNBS slightly higher at -26.18%.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

MSOS has a 0.74% expense ratio, which is lower than CNBS's 0.75% expense ratio.

This table presents a comparison of risk-adjusted performance metrics for AdvisorShares Pure US Cannabis ETF (MSOS) and Amplify Seymour Cannabis ETF (CNBS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current MSOS Sharpe Ratio is -0.87, which is comparable to the CNBS Sharpe Ratio of -0.94. The chart below compares the historical Sharpe Ratios of MSOS and CNBS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

MSOS has not paid dividends to shareholders, while CNBS's dividend yield for the trailing twelve months is around 59.01%.

The maximum MSOS drawdown since its inception was -96.20%, roughly equal to the maximum CNBS drawdown of -95.63%. Use the drawdown chart below to compare losses from any high point for MSOS and CNBS. For additional features, visit the drawdowns tool.

AdvisorShares Pure US Cannabis ETF (MSOS) has a higher volatility of 27.11% compared to Amplify Seymour Cannabis ETF (CNBS) at 19.40%. This indicates that MSOS's price experiences larger fluctuations and is considered to be riskier than CNBS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.